Le Lézard
Classified in: Health
Subjects: WOM, LGB, DEI

New Docuseries Explores the Diverse Experiences and Emotional Realities Faced by Many on the Path to Parenthood

PARSIPPANY, N.J., Nov. 29, 2023 /PRNewswire/ -- Ferring Pharmaceuticals today announced the launch of the Fertility Out Loud Docuseries on YouTube, featuring the diverse perspectives and fertility journeys of four couples as they navigate their own unique paths to parenthood. The docuseries, which is part of the company's Fertility Out Loud platform and social community designed to build awareness, provide education, and address the stigma associated with infertility, underscores Ferring's commitment to advancing fertility care through inclusivity.

"The four incredible couples highlighted in the Fertility Out Loud Docuseries humanize the varied journeys to parenthood and exemplify the emotional and sometimes very complex experience of growing a family," said David Powley, Vice President, Reproductive Medicine / Maternal Health and Operations, Ferring Pharmaceuticals U.S. "Ferring admires the passion of this community made up of people and advocates, including the couples featured in the docuseries, who share their stories to help support others navigating their own fertility journeys."

Because there's not a "one-size-fits-all approach" to becoming a parent, the Fertility Out Loud Docuseries aims to highlight the authentic and relatable personal stories of aspiring parents from across the U.S. who illustrate there are many paths to parenthood, including:

"I was personally moved by the stories shared, and hope the series helps foster a sense of hope for aspiring parents undergoing similar challenges," said Ali Castro, Senior Director, Marketing & Strategic Engagement, Ferring Pharmaceuticals U.S. "While no two paths in a fertility journey look exactly the same and needs can vary based on circumstances, one element is consistent across all paths to parenthood ? and that is the importance of an inclusive and supportive community."

The importance of active inclusion for the fertility community has recently been demonstrated by the American Society for Reproductive Medicine (ASRM), which updated its definition of infertility to address the need for equitable access to infertility treatment and care for all individuals seeking to build their families regardless of relationship status or sexual orientation.1 The significance of this evolved definition is underscored by the increasing rates of infertility and demand for assisted reproductive technology services in the U.S.2 Now more than ever, it is imperative to ensure that fertility care, education, and resources respectfully acknowledge that couples and individuals are exploring different paths to realize their dreams of becoming parents.  

Episode one of the four-part series is now available on the Fertility Out Loud YouTube channel, with the next three episodes launching through the end of 2023. Audiences are encouraged to subscribe to the Fertility Out Loud YouTube channel to receive alerts for the premieres of subsequent episodes.

For more information about Fertility Out Loud, including resources and support for the fertility journey, visit www.fertilityoutloud.com and to view the docuseries, please visit the link here.

About Ferring Pharmaceuticals
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. In the United States, Ferring is a leader in reproductive medicine and maternal health, uro-oncology and in specialty areas within orthopaedics, and gastroenterology, including microbiome therapeutics. For more information, call 1-888-FERRING (1-888-337-7464) or visit www.ferringusa.com.

About Fertility Out Loud
The mission of Fertility Out Loud is to connect with and empower people who are facing fertility challenges. Fertility Out Loud offers resources to support those on the fertility journey, including a reproductive endocrinologist (RE) finder to help those searching for a credible fertility specialist near them, and information on navigating fertility treatments, insurance, and coverage. Fertility Out Loud also fosters an inclusive social media community on Instagram and Facebook. Fertility Out Loud's offerings include Fertility Outreach, a text-based platform connecting aspiring parents with fertility coaches and Fertility House Calls, a search tool for individuals to find fertility specialists and clinics in their area.

1. Definition of infertility: A committee opinion (2023) [Internet]. 2023 [cited 2023 Nov 21]. Available from: https://www.asrm.org/practice-guidance/practice-committee-documents/denitions-of-infertility/
2. [Internet]. Harris Williams; 2022 [cited 2023 Nov 21]. Available from: https://www.harriswilliams.com/our-insights/fertility-market-overview-1

For more information, please contact:

Lisa Perdomo
Director, Brand Communications
Ferring Pharmaceuticals
[email protected]

SOURCE Ferring Pharmaceuticals

These press releases may also interest you

at 04:05
Vantage Foundation is proud to announce its strategic partnership with The IREDE Foundation, a non-profit organisation committed to empowering children between the ages of 0 - 18 living with limb loss in Nigeria to live self-sufficient lives by...

at 03:44
Integrum (publ) will host a webcast presentation of its third quarter 2023/24 results on February 29, 2024 at 14:00 CEST. Integrum's CEO Rickard Brånemark will present the report together with CFO Jörgen Svanström and US President Jeffrey Zanni in...

at 03:00
MAGENTIQ-EYE LTD., an Israeli based technology company founded in 2014, announced today that a comprehensive study on the performance of MAGENTIQ-COLOtm CADe version has been published in the prestigious Lancet Digital Health medical journal. The...

at 03:00
United Imaging, a global leader in medical technology, is showcasing its full portfolio of AI-empowered innovations at the European Society of Radiology (ECR) 2024 in Vienna, Austria.  The company highlights its significant EU growth since...

at 02:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Medicines Agency's (EMA) CHMP has...

at 01:58
FOURTH QUARTER (OCTOBER - DECEMBER 2023) Order intake SEK 317.7 M (514.4)Net sales SEK 299.6 M (264.4)Operating profit SEK 44.4 M (20.7)Profit after tax SEK 31.5 M (14.1)Earnings per share before/after dilution SEK 0.92 (0.41)Cash flow SEK 45.5 M...

News published on and distributed by: